Suppr超能文献

后疫情时代趋势:中国南方急性呼吸道感染的流行病学和病因学见解。

Post-pandemic trends: Epidemiological and etiological insights into acute respiratory infections in southern China.

机构信息

Department of Laboratory Medicine, Ningbo Hospital, Ren Ji Hospital, Shanghai Jiao Tong University School of medicine, Ningbo Hangzhou Bay Hospital, Ningbo, Zhejiang, PR China.

Department of Clinical Laboratory, Ningbo Medical Center Lihuili Hospital, Affiliated Lihuili Hospital of Ningbo University, Ningbo, PR China.

出版信息

Diagn Microbiol Infect Dis. 2024 Jul;109(3):116293. doi: 10.1016/j.diagmicrobio.2024.116293. Epub 2024 Apr 4.

Abstract

Data on people suspected with acute respiratory infections (ARIs) from August 2022 to December 2023 in southern China were analyzed. Following the COVID-19 pandemic, the positive detection rates of respiratory pathogens increased to 56.9%. Influenza A virus (IAV) emerged as the predominant prevalence pathogen (52.1%), followed by Mycoplasma pneumoniae (Mp: 21.2%), and SARS-CoV-2 (11.6%). Mp, IAV, and Human rhinovirus (HRV) infection were the primary etiologies of ARIs patients under age 18, accounting for 49.4%, 48.6%, and 21.7%, respectively. Mp, HRV, Respiratory syncytial virus (RSV), and Adenovirus (ADV) contributed to ARIs cases in virtually every month in this group, with Mp being particularly notable for its consistent presence and high co-infection rate (31.0%). IAV was predominant in the 19 to 59 age group (88.6%), SARS-CoV-2 was responsible for most of ARIs in the elderly group (82.5%). This study provides valuable insights into the dynamic nature of respiratory pathogens post COVID-19 era.

摘要

对 2022 年 8 月至 2023 年 12 月中国南方急性呼吸道感染(ARI)人群的数据进行了分析。在 COVID-19 大流行之后,呼吸道病原体的阳性检出率上升至 56.9%。甲型流感病毒(IAV)成为主要流行病原体(52.1%),其次是肺炎支原体(Mp:21.2%)和 SARS-CoV-2(11.6%)。Mp、IAV 和人类鼻病毒(HRV)感染是 18 岁以下 ARI 患者的主要病因,分别占 49.4%、48.6%和 21.7%。Mp、HRV、呼吸道合胞病毒(RSV)和腺病毒(ADV)在该组人群中几乎每个月都导致 ARI 病例,其中 Mp 尤为突出,其持续存在且高合并感染率(31.0%)。IAV 在 19 至 59 岁年龄组中占主导地位(88.6%),SARS-CoV-2 是老年人群中大多数 ARI 的罪魁祸首(82.5%)。本研究提供了有关 COVID-19 后时代呼吸道病原体动态变化的有价值的见解。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验